Based on the Rainbow Childrens Medicare Limited stock forecast from 0 analysts, the average analyst target price for Rainbow Childrens Medicare Limited is not available over the next 12 months. Rainbow Childrens Medicare Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Rainbow Childrens Medicare Limited is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, Rainbow Childrens Medicare Limited’s stock price was INR 1,300.20. Rainbow Childrens Medicare Limited’s stock price has changed by -2.94% over the past week, +15.34% over the past month and +62.51% over the last year.
No recent analyst target price found for Rainbow Childrens Medicare Limited
No recent average analyst rating found for Rainbow Childrens Medicare Limited
Company Overview Rainbow Childrens Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty paediatric and obstetrics, and gynaecology hospital chain in India. The company's children's health services include general paediatrics, intensive care unit, neonatology, surgery, gastroenterology and liver diseases, haematology and oncology, psychology, pulmonology, bone marrow transplant unit, dentistry, endocrinology, nephrology, nutrition, psychiatry, ENT, anaesthesia and pain management, cardiology, radiology, physiotherapy and rehabilitation, orthopaedics, ophthalmology, dermatology, allergy, rheumatology, and plastic surgery; and laboratory, speech and language therapy, occupational therapy, paediatric and metabolic medicine, developmental and behavioural, urology, neurosurgery, infectious disease, and cranio-maxillofacial surgery; intensive care unit, kidney transplant, and cochlear implant services; and genetics and metabolic medicines paediatrics, and cerebral palsy care services. Its women's health services comprise obstetrics and gynaecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after caesarean, breast feeding support, well women checkup, urogynaecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company's fertility care services include in vitro fertilization, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India. Read Less
Rainbow Children's Medicare Limited operates a multi-specialty paediatric and obstetrics, and gynaecology hospital chain in India. The company's children's health services include general paediatrics, intensive care unit, neonatology, surgery, gastroenterology and liver diseases,...Read More
Frequently Asked Questions About Rainbow Childrens Medicare Limited (RAINBOW:NSE) Stock
Stock Target Advisor's fundamental analysis for Rainbow Childrens Medicare Limited's stock is Slightly Bearish.
RAINBOW:NSE stock's dividend yield is 0.22%.
Our analysis grades RAINBOW:NSE stock's dividend yield at F. This means that RAINBOW:NSE stock's dividend yield is above 38% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this RAINBOW:NSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on RAINBOW:NSE's stock to indicate what its average analyst target is.
RAINBOW:NSE stock's Price/Earning ratio is 62.10.
Our analysis grades RAINBOW:NSE stock's Price / Earning ratio at F. This means that RAINBOW:NSE stock's Price/Earning ratio is above 50% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this RAINBOW:NSE may be fairly valued for its sector
The last closing price of RAINBOW:NSE's stock was INR 1,300.20.
The most recent market capitalization for RAINBOW:NSE is INR 137.06B.
Unfortunately we do not have enough analyst data on RAINBOW:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Rainbow Childrens Medicare Limited's stock.
As per our most recent records Rainbow Childrens Medicare Limited has 3,581 Employees.
Rainbow Childrens Medicare Limited's registered address is 8-2-19/1/A, Daulet Arcade, Hyderabad, India, 500034.
You can get more information about it from Rainbow Childrens Medicare Limited's website at https://www.rainbowhospitals.in.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RAINBOW:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
